Dr. Jennifer King brings expertise in molecular targets for cancer therapeutics as well as executive-level experience implementing strategic initiatives to the scientific affairs team. Read more
Dr. Jeffrey A. Bogart says that despite evidence that twice-daily radiotherapy has positive impacts on survival, the treatment has not been routinely adopted. However, considerable uncertainty remains regarding the optimal dose of once-daily radiotherapy. Read more
Dr. Jens Vogel-Claussen says the PLCOm2012 model, which includes family history and other factors, detected 97% of lung cancer cases compared to a 77% detection rate with NELSON criteria. Read more
A multivariate analysis presented by Dr. Andrea Wolf during the World Conference on Lung Cancer shows IASLC models performed well compared to other models. However, there is room for improvement, she said. Read more
Keynote addresses from renowned investigators Dr. Drew Pardoll and Prof. Laurence Zitvogel will bookend the conference. Learn more in a Q&A with the meeting chairs. Read more
October saw two approvals from the US FDA as well as caution from the agency’s Oncologic Drug Advisory Committee regarding the interpretation of CodeBreak 200 data; Takeda announces withdrawal of mobocertinib. Read more
Drs. Keith Kerr and Sanja Dacic shared findings from the IASLC Pathology Committee, which is investigating how to best assess pathologic response to neoadjuvant immunotherapy in lung cancer. Read more
During WCLC 2023, Dr. Yan Zhang presented findings that she says support the inclusion of factors such as early menarche and early menopause in lung cancer screening programs. Read more
Drs. Wendy Cooper, Melissa Culligan, And Navneet Singh concluded the session with talks on the future of pathology, enhancing the patient experience, and accurate staging in lung cancer. Read more
The challenge, Step It Up for Research, helped WCLC 23 attendees stay active during the meeting while raising money to support the IASLC Foundation, which provides grants for research, education, and other scientific initiatives. Read more